New Long-Lasting treatment tested for rare bleeding disorder
NCT ID NCT06399289
Summary
This study is testing a new, longer-lasting version of the missing clotting factor (Factor IX) for people with hemophilia B. It aims to see how well it prevents bleeding episodes and how long it stays in the body. The trial involves 23 Chinese male participants who have previously used other Factor IX treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMOPHILIA B are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Affiliated Hospital of Guizhou Medical University
Guiyang, Guizhou, 550004, China
-
Beijing Children's Hospital
Beijing, Beijing Municipality, 100045, China
-
Hospital of Hematology, Chinese Academy of Medical Sciences
Tianjin, Tianjin Municipality, 300020, China
-
Jinan Central Hospital
Jinan, Shandong, 250013, China
-
Nanfang Hospital of Southern Medical University
Guangzhou, Guangdong, 510515, China
-
North China University Of Science And Technology Affiliated Hospital
Tangshan, Hebei, 63000, China
-
Union Hospital Affiliated to Fujian Medical University
Fuzhou, Fujian, 350001, China
Conditions
Explore the condition pages connected to this study.